» Articles » PMID: 7672904

Prevalence and Sex-ratio of the Subtypes of Migraine

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 1995 Jun 1
PMID 7672904
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to provide the prevalence and sex-ratio of subtypes of migraine diagnosed by neurological interview according to the criteria of the International Headache Society.

Methods: In all, 3000 males and 1000 females aged 40 years were randomly selected from the Danish population. They received a mailed questionnaire regarding migraine. The questionnaire response rate was 87%. People with self-reported migraine and a random sample of those reporting no migraine were invited to a headache interview, and a physical and a neurological examination. Those not reacting to the invitation were interviewed by telephone. Participation at the interview was 87%. Kappa was 0.77 validating self-reported migraine in the questionnaire against the diagnosis of the clinical interview.

Results: Lifetime prevalences of migraine without aura, migraine with aura, migraine aura without headache, and migrainous disorder were 8%, 4%, 1% and 1% in males and 16%, 7%, 3% and 2% in females. Overall lifetime prevalence of any type of migraine was 18%; 12% in males and 24% in females. This is lower than the sum of the prevalences since migraine diagnoses are not mutually exclusive. The male:female ratios of migraine without aura, migraine with aura, migraine aura without headache, and migrainous disorder were approximately 1:2.

Conclusions: Migraine is more prevalent than previously thought. There was a significant preponderance in females of all the subtypes of migraine except migrainous disorder.

Citing Articles

Burden of hidden migraine among the Arab general population: a cross-sectional study.

Elzayat M, Kassab S, Nada M, El-Gilany A J Headache Pain. 2025; 26(1):45.

PMID: 40016663 PMC: 11866620. DOI: 10.1186/s10194-025-01974-9.


The influence of sex on neuroimmune communication, pain, and physiology.

Alexander S, Green A, Debner E, Ramos Freitas L, Abdelhadi H, Szabo-Pardi T Biol Sex Differ. 2024; 15(1):82.

PMID: 39439003 PMC: 11494817. DOI: 10.1186/s13293-024-00660-w.


Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.

Mistry H, Naghdi S, Brown A, Rees S, Madan J, Grove A Health Technol Assess. 2024; 28(63):1-329.

PMID: 39365169 PMC: 11474956. DOI: 10.3310/AYWA5297.


Association between migraine and the risk of vascular dementia: A nationwide longitudinal study in South Korea.

Shin H, Ha W, Kim J, Park S, Han K, Baek M PLoS One. 2024; 19(4):e0300379.

PMID: 38630676 PMC: 11023172. DOI: 10.1371/journal.pone.0300379.


Clinical features of migraine with aura: a REFORM study.

Thomsen A, Ashina H, Al-Khazali H, Rose K, Christensen R, Amin F J Headache Pain. 2024; 25(1):22.

PMID: 38350851 PMC: 10865578. DOI: 10.1186/s10194-024-01718-1.